Get started
MODERNA INCMODERNA INCMODERNA INC

MODERNA INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

MRNA trade ideas

Moderna: Sell the Break Setup Moderna - Short Term - We look to Sell a break of 137.05 (stop at 147.24) A move through bespoke support at 140.00 and we look for extended losses. Closed below the 20-day EMA. The primary trend remains bearish. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 108.99 and 103.50 Resistance: 150.00 / 170.00 / 200.00 Support: 140.00 / 120.00 / 100.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:MRNAShort
by Saxo
2
MRNA and PFE are going to crash even harder....$MRNA is currently running trials on an HIV vaccine. Why? Because they, as well $PFE, with the vaccines and the booster programs have now decimated people's immune systems. $PFE at least has other products on the market, they may ultimately survive, but this could be the end of $MRNA. People are dying of Vaccine induced AIDS. The media and world leaders (lead by Prince Harry) are now advocating for the normalization of HIV testing. WE WILL NOT FORGET, AND WE WILL NOT FORGIVE.
NASDAQ:MRNAShort
by EvilMarketMorty
MRNA - Target Hit! What Next? 🤔Continuation of previous thread where I called the start of this biotechnology bear market and the 1:1 ABC target as been hit. At the time of making the previous thread the gap down made it clear that the upthrust was a B wave topping out at the typical 0.618 with overnight selling pressure coming in. And now price has collapsed it is clear to see with long term trendline breaks and the 20 and 50WMA now as resistance that the dominant trend is now to the downside. For this reason it is most likely that price will now continue to the 1.618 @$94. It may have a small X wave bounce to make a WXY or at may just capitulate in this area for a C wave extension. And this is why i'm often less concerned about the exact EW count because it is the target fib that is what is important and relevant volatility to make that judgement. Just in the same way that if I invite you round for dinner I won't be overly concerned about the journey you take as long as you do turn up at some point. I think also in favour of price reaching $94 is that it will intersect the lower trendline and probably go oversold on the weekly RSI. From there I would imagine there will be another higher degree corrective upthrust before another leg down. Not advice.
NASDAQ:MRNAShort
by dRends35
1
MRNA 1/11/2022Well, as much as some don’t want to admit, Covid just isn’t as serious as it once was back in early 2020. With a 97-99.75 recovery rates, reduction of isolation days from 14 to 5 and no need of covid test after isolation. The dirty Politians have made their money off the vaccines and are cashing out and it reflects on the charts. Daily Chart Analysis After breaking out of continuation phase back in March 2020, MRNA went on quite the uptrend that saw price go from $25 to topping out at $497. A price increase of 1888%! The last leg of the trend was broken end of Sept. 2021. Price then fell past 200ema and pulled back in form of Bear flag to its 50 ema. The bear flag was broken, and price fell below 200ema. This was the end of the uptrend of MRNA. Here we also saw the cross of 50 and 200 EMAs further confirming the bear market. After the breakdown from bear flag, price bounce several times but the EMAs rejected the price and the downtrend continued. The downtrend is currently strengthening as it is now respecting and rejecting the 20 ema. Price is currently at support area around 215.50. Will be looking to short MRNA. Entry: 223.50 Stoploss: 261.59 Target: trailing 50 ema or 110
NASDAQ:MRNAShort
by rudcharts